1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

France

Primary Industry

Chemicals

About

Based in France, and founded in 2018, Laurypath operates as a manufacturer and supplier of tissue processing reagents and fixatives for complex oncology testing. In September 2022, Epredia, engaged in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics, and a portfolio company of KKR and PHC Holding Group, acquired Laurypath. Laurypath manufactures a variety of chemical products including nitric acid, denatured ethanol, denatured absolute ethanol, isopropanol/isopropyl alcohol, formaldehyde, ordinary saffron, methylcyclohexane, toluene, xylene, microdec EDTA, disinfectants, cleaners, demineralized water, dispenser tap cap packed in different packaging ranging from the cans, buckets, jars, bottle, and barrel. In addition, the company offers user manuals and technical data sheets.
Current Investors
Epredia

Request a demo to show more

Primary Industry
Chemicals
Sub Industries
Biotechnology, Medicinal Chemicals & Botanicals
Website
www.laurypath.fr
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Timeline of Key Events

TimeLine Events

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2016
988,896
-
(60,237)
(6.1%)
(58,386)
(5.9%)
(60,796)
(6.1%)
31 Dec 2017
97,563
(90.1%)
(41,190)
(42.2%)
(40,650)
(41.7%)
(54,912)
(56.3%)
31 Dec 2018
-
-
-
-
-
-
-
-
31 Dec 2019
-
-
-
-
-
-
-
-
31 Dec 2020
30 Jun 2021
30 Jun 2022

Unlock the recent years of financials and more for Laurypath.

Request a demo to see more.

Deals

Deals Type
Add-on
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Laurypath 05 Sep 2022
Displaying 1-1 of 1

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.